| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-05 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.21 | 6e-05 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.23 | 6e-05 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.75 | 0.0002 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |